Genmab A/S has reached an agreement to acquire Merus NV in a transaction expected to close by early in the first quarter of 2026, pending customary closing conditions. Until the deal is finalized, both companies will continue to operate independently with their current structures and responsibilities. An integration management office with representatives from various Merus departments has been established to support the transition and address questions throughout the process. Regular updates are expected as the transaction progresses.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merus NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-230186), on October 03, 2025, and is solely responsible for the information contained therein.